🇺🇸 FDA
Patent

US 9074256

Method of predicting a predisposition to QT prolongation

granted A61KA61K31/519A61P

Quick answer

US patent 9074256 (Method of predicting a predisposition to QT prolongation) held by VANDA PHARMACEUTICALS INC. expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/519, A61P, A61P25/00, A61P9/00